Reale, a former standout at UCLA, signed a contract through the 2027 season. The league recently abolished the college draft, ...

Eli Lilly is seeking to end a lawsuit filed by a pharmacy trade group against the Food and Drug Administration (FDA) by ...

Experts propose potential workarounds for obstacles to wider use of combined clinics and personalized medicine for ...

On December 20, 2024, pharmaceutical company Eli Lilly announced that the FDA approved its first and only obstructive sleep ...

The Food and Drug Administration approved Eli Lilly’s weight-loss drug Zepbound on Dec. 27 to treat sleep apnea, a common but ...

By itself, it’s not enough, but body mass index has years of evidence behind it and still has a place in clinical assessments ...

HFpEF refers to when the heart is unable to pump enough blood to meet the body’s needs. Eli Lilly said the condition is ...

The FDA has declared an end to the shortage of a popular obesity drug. The implications for consumers are complicated.

In a new study, researchers examined the health effects people experienced when they returned to still-standing homes after ...

The Food and Drug Administration (FDA) announced the approval of the weight loss drug Zepbound, generically known as ...

New Alzheimer's disease drugs, a world-first skin cancer vaccine, and personalised health apps that change the way we track ...